Fiche publication
Date publication
juillet 2014
Journal
Multiple sclerosis (Houndmills, Basingstoke, England)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme
Tous les auteurs :
Collongues N, Marignier R, Jacob A, Leite MI, Siva A, Paul F, Zephir H, Akman-Demir G, Elsone L, Jarius S, Papeix C, Mutch K, Saip S, Wildemann B, Kitley J, Karabudak R, Aktas O, Kuscu D, Altintas A, Palace J, Confavreux C, De Seze J
Lien Pubmed
Résumé
Few data are available for patients with a late onset (≥ 50 years) of neuromyelitis optica (LONMO) or neuromyelitis optica spectrum disease (LONMOSD), defined by an optic neuritis/longitudinally extensive transverse myelitis with aquaporin-4 antibodies (AQP4-Ab).
Mots clés
Age of Onset, Aged, Aged, 80 and over, Aquaporin 4, immunology, Autoantibodies, blood, Biomarkers, blood, Cause of Death, Chi-Square Distribution, Disability Evaluation, Disease Progression, Europe, epidemiology, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Motor Activity, Multivariate Analysis, Neuromyelitis Optica, diagnosis, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Retrospective Studies, Risk Factors, Severity of Illness Index, Time Factors
Référence
Mult. Scler.. 2014 07;20(8):1086-94
